Alan K. Smith - Net Worth and Insider Trading

Alan K. Smith Net Worth

The estimated net worth of Alan K. Smith is at least $16 dollars as of 2024-09-21. Alan K. Smith is the EVP, Technical Operations of Bellicum Pharmaceuticals Inc and owns about 209 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $16. Details can be seen in Alan K. Smith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan K. Smith has not made any transactions after 2018-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alan K. Smith

To

Alan K. Smith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan K. Smith owns 1 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) .

Click here to see the complete history of Alan K. Smith’s form 4 insider trades.

Insider Ownership Summary of Alan K. Smith

Ticker Comapny Transaction Date Type of Owner
BLCM Bellicum Pharmaceuticals Inc 2018-01-09 EVP & Technical Oprations

Alan K. Smith Latest Holdings Summary

Alan K. Smith currently owns a total of 1 stock. Alan K. Smith owns 209 shares of Bellicum Pharmaceuticals Inc (BLCM) as of January 9, 2018, with a value of $16.

Latest Holdings of Alan K. Smith

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BLCM Bellicum Pharmaceuticals Inc 2018-01-09 209 0.07 16

Holding Weightings of Alan K. Smith


Alan K. Smith Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan K. Smith has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the sale of 49 shares on January 9, 2018, which brought Alan K. Smith around $4,578.

Insider Trading History of Alan K. Smith

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan K. Smith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alan K. Smith Ownership Network

Ownership Network List of Alan K. Smith

No Data

Ownership Network Relation of Alan K. Smith

Insider Network Chart

Alan K. Smith Owned Company Details

What does Bellicum Pharmaceuticals Inc do?

Who are the key executives at Bellicum Pharmaceuticals Inc?

Alan K. Smith is the EVP & Technical Oprations of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .

Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bellicum Pharmaceuticals Inc Insider Transactions

No Available Data

Alan K. Smith Mailing Address

Above is the net worth, insider trading, and ownership report for Alan K. Smith. You might contact Alan K. Smith via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.

Discussions on Alan K. Smith

No discussions yet.